Patent No. EP4076461 (titled "Methods Of Schizophrenia Treatment") was filed by Intra Cellular Therapies on Dec 18, 2020. The application was issued on Jan 28, 2026.
Schizophrenia treatment for adults with mild liver impairment, avoiding dose adjustments and titration. A single 42 mg capsule is taken once daily with food to ensure steady absorption. The drug works by blocking serotonin and dopamine receptors, offering a safer profile than older antipsychotics regarding weight gain, diabetes, and stroke risk. It is not recommended for elderly patients with dementia or those taking specific interacting drugs.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description